TY - JOUR
T1 - Impact of delayed graft function on overall and graft survival in recipients of deceased donor kidney transplants
AU - Negret, María Andrea
AU - Rodriguez, Martha Patricia
AU - Díaz-Brochero, Cándida
AU - Abril, Santiago
AU - Grillo, Santiago
AU - Garcia-Padilla, Paola
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/11/12
Y1 - 2025/11/12
N2 - Delayed graft function (DGF) is a frequent complication among recipients of deceased donor kidney transplants, with an incidence rate ranging from 20% to 50%. This study aimed to evaluate the impact of DGF on both graft and overall patient survival. In a retrospective cohort of 293 patients who underwent transplantation between 2007 and 2021, demographic, clinical, and long-term follow-up data were analyzed. Patients with DGF had a significantly lower 5-year graft survival rate than did those without DGF (log-rank test: p = 0.004; DGF: 80.0%, 95% CI: 70.0% − 91.0% vs. no DGF: 92.0%, 95% CI: 89.2% − 95.9%); nevertheless, without significant differences over 10 years (log-rank test: p = 0.098; DGF: 80.0%, 95% CI: 70.0% − 91.0% vs. no DGF: 87.9%, 95% CI: 83.8% − 92.1%). Regarding the overall survival, no significant differences were observed over 5 years (log-rank test: p = 0.9; DGF: 92.7%, 95% CI: 86.1% − 99.0% vs. no DGF: 92.0%, 95% CI: 89%-96%) or at 10 years (log-rank test: p = 0.81; DGF: 89.1%, 95% CI: 81.2%-97.7% vs. no DGF: 87.9%, 95% CI: 83.8%-92.1%). Multivariate analysis indicated that DGF was not associated with an increased risk of graft loss or reduced recipient survival. These findings underscore the need for larger, prospective studies to further elucidate the long-term implications of DGF and outline clinical management strategies for kidney transplant recipients.
AB - Delayed graft function (DGF) is a frequent complication among recipients of deceased donor kidney transplants, with an incidence rate ranging from 20% to 50%. This study aimed to evaluate the impact of DGF on both graft and overall patient survival. In a retrospective cohort of 293 patients who underwent transplantation between 2007 and 2021, demographic, clinical, and long-term follow-up data were analyzed. Patients with DGF had a significantly lower 5-year graft survival rate than did those without DGF (log-rank test: p = 0.004; DGF: 80.0%, 95% CI: 70.0% − 91.0% vs. no DGF: 92.0%, 95% CI: 89.2% − 95.9%); nevertheless, without significant differences over 10 years (log-rank test: p = 0.098; DGF: 80.0%, 95% CI: 70.0% − 91.0% vs. no DGF: 87.9%, 95% CI: 83.8% − 92.1%). Regarding the overall survival, no significant differences were observed over 5 years (log-rank test: p = 0.9; DGF: 92.7%, 95% CI: 86.1% − 99.0% vs. no DGF: 92.0%, 95% CI: 89%-96%) or at 10 years (log-rank test: p = 0.81; DGF: 89.1%, 95% CI: 81.2%-97.7% vs. no DGF: 87.9%, 95% CI: 83.8%-92.1%). Multivariate analysis indicated that DGF was not associated with an increased risk of graft loss or reduced recipient survival. These findings underscore the need for larger, prospective studies to further elucidate the long-term implications of DGF and outline clinical management strategies for kidney transplant recipients.
KW - Delayed graft function
KW - Graft loss
KW - Kidney transplants
KW - Overall survival
UR - https://www.scopus.com/pages/publications/105021533251
UR - https://www.mendeley.com/catalogue/86a3c0ba-c4a7-338e-8b6b-c73a53380241/
U2 - 10.1186/s12882-025-04540-2
DO - 10.1186/s12882-025-04540-2
M3 - Article
C2 - 41225375
AN - SCOPUS:105021533251
SN - 1471-2369
VL - 26
SP - 1
EP - 9
JO - BMC Nephrology
JF - BMC Nephrology
M1 - 633
ER -